You are here:

Vistin's Metformin products

Metformin is the standard first line treatment for Type 2 Diabetes, a disease that is expected to grow by 50% until 2030 worldwide and affect more than 500 million people. The global market for Metformin is expected to grow with a CAGR of 4-6% on an annual basis. Vistin Pharma is strategically well positioned to take part of this growth.

Vistin Pharma has the following product offerings:

Metformin HCl (API)

Metformin DC (direct compressible granules)

Customized Particle Distribution (PSD)

Premix (*)

Our high quality Metformin is sold to well reputable international pharmaceutical companies

* Premix: Metformin + MgSt, can be delivered on-request



Recommendation sent!

Your friend has been mailed an recommendation about this article.

Tips en venn

Vistin Pharma AS
Østensjøveien 27
P.O. Box 6735 Etterstad
NO-0609 Oslo, Norway
Tel: +47 35 98 42 00
VAT No: NO813120232MVA